Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Practical Gynecology and Obstetrics ; (12): 438-441, 2019.
Artigo em Chinês | WPRIM | ID: wpr-816198

RESUMO

OBJECTIVE: To discuss the clinical effects of clomiphene citrate combined with low molecular weight heparin calcium in the treatment of patients with polycystic ovarian syndrome(PCOS)infertility. METHODS: A total of 105 patients with PCOS infertility who were admitted to the Outpatient Department of Women and Children's Hospital of Qingdao University from September 2016 to April 2018 were taken as research subjects.They were randomly divided into observation group(57 cases)and control group(48 cases).The control group received clomiphene citrate for ovulation treatment,the observation group was given clomiphene citrate combined with low molecular weight heparin calcium for ovulation treatment,and the endometrial receptivity changes,pregnancy rate and the incidence of adverse reactions of patients were compared between the two groups.RESULTS: In the observation group,the endometrial thickness,blood flow index(FI),endometrial spiral arterial blood flow resistance index(RI)and pulsatility index(PI)decreased,and the pregnancy rate was better than that in the control group;the difference was statistically significan(t P0.05).CONCLUSION: Clomiphene citrate combined with low molecular weight heparin calcium in the treatment of polycystic ovary syndrome infertility can improve the treatment efficiency,and is safe and reliable.It is worthy of clinical promotion.

2.
Chinese Journal of Oncology ; (12): 48-52, 2009.
Artigo em Chinês | WPRIM | ID: wpr-255565

RESUMO

<p><b>OBJECTIVE</b>To clarify the association of EGFR expression with angiogenesis and chemoresistance in ovarian cancer.</p><p><b>METHODS</b>Immunohistochemical PV-6000 staining was used to detect the expression of EGFR, LRP protein and MVD in 102 ovarian tumor specimens.</p><p><b>RESULTS</b>EGFR, LRP positive rates and MVD in borderline and malignant ovarian specimens were significantly higher than those in the normal and benign ones (P < 0.01). EGFR positive expression rate in stage III-IV carcinoma tissues, poor differentiation and with ascites was higher than that in stage I-II carcinomas of well differentiation and without ascites (P < 0.05). MVD was related to histological grade, residual tumor and ascites, LRP positive expression had no correlation with the clinicopathologic parameters (P > 0.05). The effective rate of chemotherapy in patients with EGFR and LRP-positive expression were 57.1% and 53.7%, respectively, significantly lower than that in cases with EGFR and LRP-negative expression (85.0% and 90.9%, P < 0.05). In the 64 cases with complete data, the three-year survival rate was 53.0%. The survival time was shorter in the cases with EGFR and LRP-positive expression, poor differentiation, ascites and chemoresistance (P < 0.01), and only LRP-positive expression and chemotherapeutic effect were independently related to survival time (P < 0.05). There was a correlation between EGFR and MVD (r = 0.548, P < 0.01), EGFR and LRP positive expression (P = 0.020).</p><p><b>CONCLUSION</b>The expression of EGFR in ovarian cancer is related to angiogenesis and chemoresistance. EGFR and LRP-positive expression are related to chemoresistance, and detection of the two proteins may be helpful in guiding chemotherapy choice for ovarian cancer. LRP-positive expression and chemotherapeutic effect may be independent prognostic factors.</p>


Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Antígenos CD34 , Metabolismo , Ascite , Patologia , Cistadenocarcinoma Mucinoso , Tratamento Farmacológico , Metabolismo , Patologia , Cistadenocarcinoma Seroso , Tratamento Farmacológico , Metabolismo , Patologia , Cistadenoma Mucinoso , Tratamento Farmacológico , Metabolismo , Patologia , Cistadenoma Seroso , Tratamento Farmacológico , Metabolismo , Patologia , Resistência a Múltiplos Medicamentos , Resistencia a Medicamentos Antineoplásicos , Seguimentos , Regulação Neoplásica da Expressão Gênica , Metástase Linfática , Estadiamento de Neoplasias , Neovascularização Patológica , Patologia , Neoplasias Ovarianas , Tratamento Farmacológico , Metabolismo , Patologia , Receptores ErbB , Metabolismo , Taxa de Sobrevida , Partículas de Ribonucleoproteínas em Forma de Abóbada , Metabolismo
3.
Chinese Journal of Biotechnology ; (12): 481-485, 2002.
Artigo em Chinês | WPRIM | ID: wpr-256180

RESUMO

Poplar(Pupulus x Xiao zhannica, cv. "balizhuang-yang") transferred with mtl-D gene was used as an experimental material. Through tissue culture, aquaculture and pot culture transgenic poplars are tested with variant Nacl salt gradient. In it transgenic poplar raises its initial days for differentiation, differentiation rate, bud intensity, bud height and growth potential than control plant. At the same time, the transgenic poplar has higher rooting rate and more top roots, side roots and higher root length than control under the same salt stress. The result shows that the transgenic poplar has better tolerance ability than control plant in the salt 4@1000 contensity mediums.


Assuntos
Adaptação Fisiológica , Genética , Relação Dose-Resposta a Droga , Resistência a Medicamentos , Genética , Plantas Geneticamente Modificadas , Populus , Genética , Cloreto de Sódio , Farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA